FBInvestor
Stocks / Coeptis Therapeutics Hldgs I
Institutional Ownership

Coeptis Therapeutics Hldgs I

CUSIP 19207A116*W EXP 10/28/202COEPWQ1 2026

Earnings

Quarterly EPS and revenue are sourced from SEC XBRL financial statements. We ingest the top issuers first; this fills in as coverage expands (or this security isn't mapped to an SEC filer yet).

Coming soon